Colorcon || One Partner
ACROBiosystems - Survey NA

Projects

The pharmaceutical projects listed in this phase are those that receive periodic global announcements.

AstraZeneca Invests $1.5 Billion to Construct Antibody Drug Conjugate Facility in Singapore

AstraZeneca has announced a significant investment of $15 billion to establish a stateoftheart manufacturing facility in Singapore, dedicated to the production of AntibodyDrug Conjugates ADCs This facility will play a pivotal role in advancing the companys efforts to deliver cuttingedge cancer treatments

Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.

Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization

Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky

Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate

AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S

AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering

Grünenthal Invests €80 Million to Enhance Latin American Production

Grnenthal, a prominent pharmaceutical company specializing in pain management and research, has announced a significant investment in its Latin American production facilities, exceeding 80 million

Kyowa Kirin Plans $530 Million Investment for New Biologics Manufacturing Plant in North Carolina

Kyowa Kirin, Inc, a global specialty pharmaceutical company headquartered in Japan, has announced plans to invest up to $530 million in building a new manufacturing facility in Sanford, North Carolina

Merck Invests €62 Million in New Quality Control Center in Germany

Merck, a leading science and technology company, is investing 62 million in a new quality control facility for its Life Science division at its Darmstadt headquarters

AstraZeneca's $1.5B Investment in Singapore for Antibody Drug Conjugates

AstraZeneca has announced plans to invest $15 billion in a new manufacturing facility in Singapore dedicated to antibodydrug conjugates

AbbVie Invests €150 Million in New Research and Development Facility in Germany

AbbVie has initiated the construction of its new central research facility, LUnA, at its main campus in Ludwigshafen, RhinelandPalatinate, Germany

€80 Million Investment by GEA to Enhance Pharmaceutical Standards at Elsdorf Factory

GEA has announced a substantial investment of 80 million to enhance pharmaceutical production standards at its Elsdorf factory, aiming to modernize facilities and improve operational efficiency